Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon D Roger

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Journal of the American Society of Nephrology : JASN|February 4, 2005
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter studyJill S Lindberg, Bruce Culleton, Gordon Wong, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 2016
A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized TrialRichard A Brigandi, Brendan Johnson, Coreen Oei, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2008
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysisMichel Chonchol, Francesco Locatelli, Hanna E Abboud, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 22, 2019
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 StudyBruce S Spinowitz, Steven Fishbane, Pablo E Pergola, et al.
The Medical Journal of Australia|November 2, 2010
Diagnosis and management of iron deficiency anaemia: a clinical updateSant-Rayn S Pasricha, Stephen C Flecknoe-Brown, Katrina J Allen, et al.
BMC Public Health|July 1, 2011
Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocolGermaine Wong, Kirsten Howard, Jeremy R Chapman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2011
C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysisSimon D Roger, Francesco Locatelli, Rainer P Woitas, et al.
Kidney International Reports|July 18, 2025
Participant Perceptions of Increasing Water Intake in Polycystic Kidney DiseaseSneha Amin, Irene Sangadi, Margaret Allman-Farinelli, et al.
Clinical Kidney Journal|August 21, 2024
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney diseaseGopala Rangan, Margaret Allman-Farinelli, Neil Boudville, et al.
Kidney International Reports|March 18, 2021
Roxadustat for CKD-related Anemia in Non-dialysis PatientsDaniel W Coyne, Simon D Roger, Sug Kyun Shin, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Journal of the American Society of Nephrology : JASN|February 4, 2005
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter studyJill S Lindberg, Bruce Culleton, Gordon Wong, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 2016
A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized TrialRichard A Brigandi, Brendan Johnson, Coreen Oei, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2008
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysisMichel Chonchol, Francesco Locatelli, Hanna E Abboud, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 22, 2019
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 StudyBruce S Spinowitz, Steven Fishbane, Pablo E Pergola, et al.
The Medical Journal of Australia|November 2, 2010
Diagnosis and management of iron deficiency anaemia: a clinical updateSant-Rayn S Pasricha, Stephen C Flecknoe-Brown, Katrina J Allen, et al.
BMC Public Health|July 1, 2011
Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocolGermaine Wong, Kirsten Howard, Jeremy R Chapman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2011
C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysisSimon D Roger, Francesco Locatelli, Rainer P Woitas, et al.
Kidney International Reports|July 18, 2025
Participant Perceptions of Increasing Water Intake in Polycystic Kidney DiseaseSneha Amin, Irene Sangadi, Margaret Allman-Farinelli, et al.
Clinical Kidney Journal|August 21, 2024
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney diseaseGopala Rangan, Margaret Allman-Farinelli, Neil Boudville, et al.
Kidney International Reports|March 18, 2021
Roxadustat for CKD-related Anemia in Non-dialysis PatientsDaniel W Coyne, Simon D Roger, Sug Kyun Shin, et al.
Pageof 8